Response to SGX Queries::

Issuer & Securities

Issuer/ Manager
PHARMESIS INTERNATIONAL LTD.
Securities
PHARMESIS INTERNATIONAL LTD. - SG1BH6000003 - BFK
Stapled Security
No

Announcement Details

Announcement Title
Response to SGX Queries
Date &Time of Broadcast
07-Mar-2022 17:39:32
Status
New
Supplementary Title
On Financial Statements
Announcement Reference
SG220307OTHRXOOF
Submitted By (Co./ Ind. Name)
Mr. Wu Xuedan
Designation
Executive Director and Chief Executive Officer
Description (Please provide a detailed description of the change in the box below)
Please refer to the attachment.

Attachments

Related Announcements

Related Announcements

08/03/2022 17:25:57